Allos Therapeutics, Inc. (ALTH)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
06-Sep-12 4:17 PM
View: 
Warburg Pincus Private Equi...
Director
10% Owner
Allos Therapeutics, Inc. (ALTH) 05-Sep-12Disposition (change in control) 26,124,400$1.82$47,546,500.00(100%)
26.12M to 0
(1%)
05-Sep-12 4:50 PM
View: 
Hoffman Stephen J
Director
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 473,671$1.82$862,081.00(100%)
473.67K to 0
(< 1%)
05-Sep-12 4:45 PM
View: 
Graboyes Marc H
SVP, General Counsel
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 542,028$1.82$986,491.00(100%)
542.03K to 0
(< 1%)
05-Sep-12 4:53 PM
View: 
Leff Jonathan S
Director
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 55,000$1.82$100,100.00(100%)
55.0K to 0
(< 1%)
05-Sep-12 4:43 PM
View: 
Bennett Bruce K Jr
VP, Pharmaceutical Operations
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 148,482$1.82$270,237.00(100%)
148.48K to 0
(< 1%)
05-Sep-12 4:48 PM
View: 
Schick Michael E
VP, Sales and Marketing
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 285,113$1.82$518,906.00(100%)
285.11K to 0
(< 1%)
05-Sep-12 4:54 PM
View: 
Stout David M
Director
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 35,000$1.82$63,700.00(100%)
35.0K to 0
(< 1%)
05-Sep-12 4:46 PM
View: 
Goldsmith Bruce A
SVP, Corporate Development
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 346,933$1.82$631,418.00(100%)
346.93K to 0
(< 1%)
05-Sep-12 4:41 PM
View: 
Berns Paul L
Chief Executive Officer
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 1,233,320$1.82$2,244,650.00(100%)
1.23M to 0
(< 1%)
05-Sep-12 4:50 PM
View: 
Hoffman Stephen J
Director
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 92,000$1.82$167,440.00(16%)
565.67K to 473.67K
(< 1%)
05-Sep-12 4:44 PM
View: 
Clark Dsvid C
VP, Finance
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 207,114$1.82$376,948.00(100%)
207.11K to 0
(< 1%)
05-Sep-12 4:55 PM
View: 
Turner Joseph L
Director
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 55,000$1.82$100,100.00(100%)
55.0K to 0
(< 1%)
05-Sep-12 4:52 PM
View: 
Latts Jeffrey
Director
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 55,000$1.82$100,100.00(100%)
55.0K to 0
(< 1%)
05-Sep-12 4:47 PM
View: 
Morris Charles Q
Chief Medical Officer
Allos Therapeutics, Inc. (ALTH) 04-Sep-12Disposition (change in control) 655,031$1.82$1,192,160.00(100%)
655.03K to 0
(< 1%)
13-Jul-12 4:40 PM
View: 
Schick Michael E
VP, Sales and Marketing
Allos Therapeutics, Inc. (ALTH) 11-Jul-12Market Sale (Planned) 697$1.78$1,241.50(< 1%)
285.81K to 285.11K
< 1%
30-Apr-12 4:59 PM
View: 
Bennett Bruce K Jr
VP, Pharmaceutical Operations
Allos Therapeutics, Inc. (ALTH) 27-Apr-12Private Purchase 1,104$1.22$1,341.91< 1%
147.38K to 148.48K
30-Apr-12 4:58 PM
View: 
Morris Charles Q
Chief Medical Officer
Allos Therapeutics, Inc. (ALTH) 27-Apr-12Market Sale (Planned) 7,970$1.81$14,426.50(1%)
673.29K to 665.32K
(< 1%)
01-Mar-12 6:14 PM
View: 
Goldsmith Bruce A
SVP, Corporate Development
Allos Therapeutics, Inc. (ALTH) 01-Mar-12Market Sale (Planned) 4,473$1.50$6,690.27(1%)
351.41K to 346.93K
2%
01-Mar-12 6:15 PM
View: 
Berns Paul L
Chief Executive Officer
Allos Therapeutics, Inc. (ALTH) 01-Mar-12Market Sale (Planned) 21,532$1.48$31,815.70(2%)
1.25M to 1.23M
1%
01-Mar-12 6:15 PM
View: 
Clark Dsvid C
VP, Finance
Allos Therapeutics, Inc. (ALTH) 01-Mar-12Market Sale (Planned) 3,385$1.50$5,073.44(2%)
210.5K to 207.11K
3%
01-Mar-12 6:12 PM
View: 
Schick Michael E
VP, Sales and Marketing
Allos Therapeutics, Inc. (ALTH) 01-Mar-12Market Sale (Planned) 3,960$1.48$5,865.95(1%)
289.77K to 285.81K
(< 1%)
01-Mar-12 6:13 PM
View: 
Graboyes Marc H
SVP, General Counsel
Allos Therapeutics, Inc. (ALTH) 01-Mar-12Market Sale (Planned) 9,635$1.48$14,259.80(2%)
551.66K to 542.03K
1%
01-Mar-12 6:16 PM
View: 
Bennett Bruce K Jr
VP, Pharmaceutical Operations
Allos Therapeutics, Inc. (ALTH) 01-Mar-12Market Sale (Planned) 3,025$1.50$4,522.38(2%)
150.4K to 147.38K
2%
01-Mar-12 6:15 PM
View: 
Clark Dsvid C
VP, Finance
Allos Therapeutics, Inc. (ALTH) 29-Feb-12Market Sale (Planned) 3,388$1.52$5,164.67(2%)
213.89K to 210.5K
4%
01-Mar-12 6:13 PM
View: 
Morris Charles Q
Chief Medical Officer
Allos Therapeutics, Inc. (ALTH) 29-Feb-12Market Sale (Planned) 10,155$1.52$15,478.30(1%)
683.45K to 673.29K
2%
01-Mar-12 6:12 PM
View: 
Schick Michael E
VP, Sales and Marketing
Allos Therapeutics, Inc. (ALTH) 29-Feb-12Market Sale (Planned) 3,894$1.52$5,934.85(1%)
293.66K to 289.77K
2%
01-Mar-12 6:13 PM
View: 
Graboyes Marc H
SVP, General Counsel
Allos Therapeutics, Inc. (ALTH) 29-Feb-12Market Sale (Planned) 9,425$1.52$14,365.60(2%)
561.09K to 551.66K
4%
01-Mar-12 6:16 PM
View: 
Bennett Bruce K Jr
VP, Pharmaceutical Operations
Allos Therapeutics, Inc. (ALTH) 29-Feb-12Market Sale (Planned) 3,031$1.53$4,622.88(2%)
153.43K to 150.4K
4%
01-Mar-12 6:14 PM
View: 
Goldsmith Bruce A
SVP, Corporate Development
Allos Therapeutics, Inc. (ALTH) 29-Feb-12Market Sale (Planned) 4,505$1.52$6,869.22(1%)
355.91K to 351.41K
4%
01-Mar-12 6:15 PM
View: 
Berns Paul L
Chief Executive Officer
Allos Therapeutics, Inc. (ALTH) 29-Feb-12Market Sale (Planned) 21,163$1.52$32,235.50(2%)
1.28M to 1.25M
4%
01-Mar-12 6:14 PM
View: 
Goldsmith Bruce A
SVP, Corporate Development
Allos Therapeutics, Inc. (ALTH) 28-Feb-12Grant 179,727----102%
176.18K to 355.91K
01-Mar-12 6:13 PM
View: 
Morris Charles Q
Chief Medical Officer
Allos Therapeutics, Inc. (ALTH) 28-Feb-12Grant 241,848----55%
441.6K to 683.45K
01-Mar-12 6:15 PM
View: 
Clark Dsvid C
VP, Finance
Allos Therapeutics, Inc. (ALTH) 28-Feb-12Grant 99,779----87%
114.11K to 213.89K
01-Mar-12 6:12 PM
View: 
Schick Michael E
VP, Sales and Marketing
Allos Therapeutics, Inc. (ALTH) 28-Feb-12Grant 135,545----86%
158.12K to 293.66K
01-Mar-12 6:15 PM
View: 
Berns Paul L
Chief Executive Officer
Allos Therapeutics, Inc. (ALTH) 28-Feb-12Grant 573,506----82%
702.51K to 1.28M
01-Mar-12 6:13 PM
View: 
Graboyes Marc H
SVP, General Counsel
Allos Therapeutics, Inc. (ALTH) 28-Feb-12Grant 222,266----66%
338.82K to 561.09K
01-Mar-12 6:16 PM
View: 
Bennett Bruce K Jr
VP, Pharmaceutical Operations
Allos Therapeutics, Inc. (ALTH) 28-Feb-12Grant 43,862----40%
109.57K to 153.43K
27-Feb-12 5:40 PM
View: 
Graboyes Marc H
SVP, General Counsel
Allos Therapeutics, Inc. (ALTH) 24-Feb-12Market Sale (Planned) 1,380$1.54$2,125.34(< 1%)
340.2K to 338.82K
(3%)
27-Feb-12 5:43 PM
View: 
Bennett Bruce K Jr
VP, Pharmaceutical Operations
Allos Therapeutics, Inc. (ALTH) 24-Feb-12Market Sale (Planned) 1,469$1.55$2,277.10(1%)
111.04K to 109.57K
(2%)
27-Feb-12 5:43 PM
View: 
Goldsmith Bruce A
SVP, Corporate Development
Allos Therapeutics, Inc. (ALTH) 24-Feb-12Market Sale (Planned) 575$1.54$888.09(< 1%)
176.76K to 176.18K
(2%)
27-Feb-12 5:44 PM
View: 
Berns Paul L
Chief Executive Officer
Allos Therapeutics, Inc. (ALTH) 24-Feb-12Market Sale (Planned) 4,350$1.55$6,742.94(< 1%)
706.86K to 702.51K
(2%)
27-Feb-12 5:42 PM
View: 
Clark Dsvid C
VP, Finance
Allos Therapeutics, Inc. (ALTH) 24-Feb-12Market Sale (Planned) 595$1.55$922.31(< 1%)
114.7K to 114.11K
(2%)
27-Feb-12 5:43 PM
View: 
Goldsmith Bruce A
SVP, Corporate Development
Allos Therapeutics, Inc. (ALTH) 23-Feb-12Market Sale (Planned) 2,500$1.58$3,958.00(1%)
179.26K to 176.76K
< 1%
27-Feb-12 5:44 PM
View: 
Berns Paul L
Chief Executive Officer
Allos Therapeutics, Inc. (ALTH) 23-Feb-12Market Sale (Planned) 9,100$1.56$14,196.00(1%)
715.96K to 706.86K
(1%)
27-Feb-12 5:42 PM
View: 
Clark Dsvid C
VP, Finance
Allos Therapeutics, Inc. (ALTH) 23-Feb-12Market Sale (Planned) 1,460$1.57$2,290.59(1%)
116.16K to 114.7K
(< 1%)
27-Feb-12 5:40 PM
View: 
Graboyes Marc H
SVP, General Counsel
Allos Therapeutics, Inc. (ALTH) 23-Feb-12Market Sale (Planned) 3,950$1.58$6,253.64(1%)
344.15K to 340.2K
< 1%
27-Feb-12 5:43 PM
View: 
Bennett Bruce K Jr
VP, Pharmaceutical Operations
Allos Therapeutics, Inc. (ALTH) 23-Feb-12Market Sale (Planned) 4,484$1.58$7,085.17(4%)
115.53K to 111.04K
< 1%
27-Feb-12 5:41 PM
View: 
Schick Michael E
VP, Sales and Marketing
Allos Therapeutics, Inc. (ALTH) 23-Feb-12Market Sale (Planned) 1,645$1.58$2,599.10(1%)
159.76K to 158.12K
(< 1%)
03-Jan-12 4:42 PM
View: 
Bennett Bruce K Jr
VP, Pharmaceutical Operations
Allos Therapeutics, Inc. (ALTH) 30-Dec-11Private Purchase 1,173$1.21$1,415.811%
114.35K to 115.53K
15-Dec-11 4:32 PM
View: 
Stout David M
Director
Allos Therapeutics, Inc. (ALTH) 13-Dec-11Grant 35,000----100%
0 to 35.0K